Industry News
Pharmaceutical Industry News
The FDA is not feeling the love in…
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
A now-deleted LinkedIn post from a…
A now-deleted LinkedIn post from a top FDA official has raised the hackles of Aurinia Pharmaceuticals as industry watchers puzzle over the official's decision to target the approvability of surrogate endpoints—and single out Aurinia’s lupus
Laboratorios Farmacéuticos Rovi,…
Laboratorios Farmacéuticos Rovi, which goes by Rovi, inked a $250 million deal with Bristol Myers Squibb that gives the Spanish CDMO a vaccine and biosimilar production facility in Phoenix as part of an overall manufacturing
True Crime to Stream: Medical Mayhem
Across television, film and podcast, these four stories use personal tragedies as a way to illuminate bigger institutional failures in health care.
Bill Nye is back in the lab….
Bill Nye is back in the lab. Backed by Biogen, the television presenter is starring in a four-part web series that brings the quirky humor of “Bill Nye the Science Guy” to the science of
Two clinical trials of Merck’s…
Two clinical trials of Merck’s pulmonary arterial hypertension drug Winrevair were so conclusive that the studies were halted because the efficacy of the treatment was assured. Now, Merck has reported results from the phase 3
Lance Hill and Jason Smith…
Lance Hill and Jason Smith highlight AI, data and evolving strategies for commercial and medical affairs teams
Based in Poland, biologics-focused…
Based in Poland, biologics-focused CDMO Rezon Bio announced its launch on the European contracting scene Monday. The company plans to use its biosimilars know-how to make development and commercialization processes simple and straightforward for partners.
The results, coupled with a prior…
The results, coupled with a prior win, could set up Enhertu to be a "foundational treatment option” in the curative-intent breast cancer setting, AstraZeneca and Daiichi Sankyo said.
Kedrion Biopharma has scored an…
Kedrion Biopharma has scored an FDA approval for Qivigy, a treatment for adults with primary humoral immunodeficiency (PI). Along with the nod, the Italian company announced plans to boost its investment in the United States.
Elawadhi points to predictive AI…
Elawadhi points to predictive AI and regulations as drivers of smarter, more personalized engagement.
In laying out their respective…
In laying out their respective plans Monday to launch new direct-to-patient platforms paring down the prices of popular medicines in the U.S., Novartis and Boehringer Ingelheim are falling in line with demands from President Donald
In a bid to “harmonize its share…
In a bid to “harmonize its share listing structure,” AstraZeneca aims to list its shares directly on the New York Stock Exchange. While AZ will continue to trade on the London Stock Exchange and retain
As pharma companies work to…
As pharma companies work to respond to President Donald Trump's drug pricing demands, PhRMA is touting three "major actions" by its members and calling for some policy shifts of its own.
The first woman to take the helm…
The first woman to take the helm of any Big Pharma is stepping down in January as GSK’s chief Emma Walmsley will move aside for her chief commercial officer Luke Miels.
How Trump’s Latest Tariffs May Affect Your Medicines
The president said he would impose a tariff of 100 percent on certain brand-name drugs. Here’s what we know so far.
Trump’s Pharma Tariffs Spare Richest Drugmakers
The details of the president’s proposed tariffs were not clear. But it seemed that many big companies would qualify for exemptions.
Trump Expands Tariffs Beyond Supreme Court’s Reach
The president’s tariffs on foreign drugs and furniture rely on national security laws outside the scope of current lawsuits.
Jeff Keller discusses technology,…
Jeff Keller discusses technology, stakeholder needs and evolving pharma roles
Kristin Cahill says industry must…
Kristin Cahill says industry must focus on impact over vanity metrics